Review of HIV antiretroviral drug resistance

被引：17

作者：

Fisher, Margaret C. ^{[1
]}

Overturf, Gary D.

Cappello, Michael

Leach, Charles T.

Weinberg, Geoffrey A.

Chadwick, Ellen G.

McGann, Kathleen

Weiner, Leonard

Englund, Junet A.

Read, Jenniter S.

Woods, Charles R.

Krilov, Leonard R.

Starke, Jcffrcy R.

机构：

[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

来源：

PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2008年 / 27卷 / 08期

关键词：

HIV; drug resistance;

D O I：

10.1097/INF.0b013e3181846e2e

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：749 / 752

页数：4

共 14 条

[1] Geno2pheno:: estimating phenotypic drug resistance from HIV-1 genotypes [J].

Beerenwinkel, N ;

Däumer, M ;

Oette, M ;

Korn, K ;

Hoffmann, D ;

Kaiser, R ;

Lengauer, T ;

Selbig, J ;

Walter, H .

NUCLEIC ACIDS RESEARCH, 2003, 31 (13) :3850-3855

[2] Prevalence and risk factors associated with antiretroviral resistance in HIV-1-infected children [J].

Delaugerre, Constance ;

Warszawski, Josiane ;

Chaix, Marie-Laure ;

Veber, Florence ;

Macassa, Eugenia ;

Buseyne, Florence ;

Rouzioux, Christine ;

Blanche, Stephane .

JOURNAL OF MEDICAL VIROLOGY, 2007, 79 (09) :1261-1269

[3] Phenotypic and genotypic resistance assays: Methodology, reliability, and interpretations [J].

Demeter, L ;

Haubrich, R .

JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 :S3-S9

[4]

Gallant Joel E, 2005, Top HIV Med, V13, P138

[5] Treatment for adult HIV infection - 2006 recommendations of the International AIDS Society-USA panel [J].

Hammer, Scott M. ;

Saag, Michael S. ;

Schechter, Mauro ;

Montaner, Julio S. G. ;

Schooley, Robert T. ;

Jacobsen, Donna M. ;

Thompson, Melanie A. ;

Carpenter, Charles C. J. ;

Fischl, Margaret A. ;

Gazzard, Brian G. ;

Gatell, Jose M. ;

Hirsch, Martin S. ;

Katzenstein, David A. ;

Richman, Douglas D. ;

Vella, Stefano ;

Yeni, Patrick G. ;

Volberding, Paul A. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (07) :827-843

[6]

Kuritzkes Daniel R, 2007, Top HIV Med, V15, P150

[7] Web resources for HIV type 1 genotypic-resistance test interpretation [J].

Liu, TF ;

Shafer, RW .

CLINICAL INFECTIOUS DISEASES, 2006, 42 (11) :1608-1618

[8] Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors [J].

Maggiolo, F ;

Ravasio, L ;

Ripamonti, D ;

Gregis, G ;

Quinzan, G ;

Arici, C ;

Airoldi, M ;

Suter, F .

CLINICAL INFECTIOUS DISEASES, 2005, 40 (01) :158-163

[9] Effect of adherence to HAART on viroloaic outcome and on the selection of resistance-conferring mutations in NNRTI- or PI-Treated patients [J].

Maggiolo, Franco ;

Airoldi, Monica ;

Kleinloog, Hendrik Daniel ;

Callegaro, Annapaola ;

Ravasio, Veronica ;

Arici, Claudio ;

Bombana, Enrico ;

Suter, Fredy .

HIV CLINICAL TRIALS, 2007, 8 (05) :282-292

[10]

*PAN ANT GUID AD A, 2008, GUID US ANT AG HIV 1

← 1 2 →